市場調査レポート
商品コード
1386046

肝疾患診断の世界市場:~2029年

Global Liver Disease Diagnostics Market Insights, Forecast to 2029

出版日: | 発行: QYResearch | ページ情報: 英文 154 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=154.64円
肝疾患診断の世界市場:~2029年
出版日: 2023年11月27日
発行: QYResearch
ページ情報: 英文 154 Pages
納期: 2~3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の肝疾患診断の市場規模は、2023年の133億6,164万米ドルから、予測期間中は7.05%のCAGRで推移し、2029年には201億298万米ドルの規模に成長すると予測されています。

地域別で見ると、2022年の市場規模は、北米市場が50億1,920万米ドル、アジア太平洋市場が30億3,697万米ドル、欧州市場が36億9,005万米ドルを示しており、同年の世界市場におけるシェアは、北米が40.95%、アジア太平洋が24.78%、欧州が30.11%を示しています。アジア太平洋地域のシェアは2029年には28.57%に達する見通しであり、同地域の予測期間中のCAGRは8.99%となると予測されています。

当レポートでは、世界の肝疾患診断の市場を調査し、市場および製品の概要、競合情勢、市場規模の推移・予測、各種区分・地域/主要国別の詳細分析、価格動向、市場成長への各種影響因子の分析、主要企業の分析などをまとめています。

目次

第1章 レポート概要

  • 調査範囲
  • 市場分析:タイプ別
    • 成長率:2018年 vs 2022年 vs 2029年
    • 画像検査
    • 血液検査
    • 生検
  • 市場:用途別
    • 市場シェア:2018年 vs 2022年 vs 2029年
    • 病院・診療所
    • 診断センター
    • その他
  • 前提と制限
  • 調査目的
  • 調査年数

第2章 世界の成長動向

  • 市場の展望
  • 成長動向:地域別
    • 市場規模:2018年 vs 2022年 vs 2029年
    • 市場規模の推移
    • 市場規模の予測
  • 市場力学
    • 産業動向
    • 市場促進要因
    • 市場の課題
    • 市場抑制要因

第3章 競合情勢:主要企業別

  • 収益・収益シェア:企業別
  • 市場シェア:企業タイプ別
  • 世界の主要企業:収益ランキング
  • 市場集中率
  • 世界の主要企業:本社・製造拠点
  • 世界の主要企業:提供製品
  • 世界の主要企業::設立日
  • M&A・拡張計画

第4章 肝疾患診断の内訳データ:タイプ別

  • 市場規模の推移・予測

第5章 肝疾患診断の内訳データ:用途別

  • 市場規模の推移・予測

第6章 北米

第7章 欧州

第8章 アジア太平洋地域

第9章 ラテンアメリカ

第10章 中東・アフリカ

第11章 主要企業のプロファイル

  • Abbott
  • Roche
  • Thermo Fisher Scientific
  • Randox Diagnostic Centers
  • Boston Scientific Corporation
  • LabCorp
  • Fujifilm Corporation
  • Siemens Healthineers
  • BD
  • Cook Medical
  • GE Healthcare
  • Philips Healthcare
  • Canon Medical Systems
  • Qiagen

第12章 アナリストによる見解・総論

第13章 付録

図表

List of Tables

  • Table 1. Global Liver Disease Diagnostics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
  • Table 2. Global Liver Disease Diagnostics Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
  • Table 3. Global Liver Disease Diagnostics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
  • Table 4. Global Liver Disease Diagnostics Market Size by Region (2018-2023) & (US$ Million)
  • Table 5. Global Liver Disease Diagnostics Market Share by Region (2018-2023)
  • Table 6. Global Liver Disease Diagnostics Forecasted Market Size by Region (2024-2029) & (US$ Million)
  • Table 7. Global Liver Disease Diagnostics Market Share by Region (2024-2029)
  • Table 8. Liver Disease Diagnostics Market Trends
  • Table 9. Liver Disease Diagnostics Market Drivers
  • Table 10. Liver Disease Diagnostics Market Challenges
  • Table 11. Liver Disease Diagnostics Market Restraints
  • Table 12. Global Liver Disease Diagnostics Revenue by Players (2018-2023) & (US$ Million)
  • Table 13. Global Liver Disease Diagnostics Market Share by Players (2018-2023)
  • Table 14. Global Top Liver Disease Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liver Disease Diagnostics as of 2021)
  • Table 15. Global Liver Disease Diagnostics Industry Ranking in 2022
  • Table 16. Global 5 Largest Players Market Share by Liver Disease Diagnostics Revenue (CR5 and HHI) & (2018-2023)
  • Table 17. Global Key Players of Liver Disease Diagnostics, Headquarters and Manufacturing Sites
  • Table 18. Global Key Players of Liver Disease Diagnostics Product
  • Table 19. Global Key Players of Liver Disease Diagnostics, Founded Date
  • Table 20. Mergers & Acquisitions, Expansion Plans
  • Table 21. Global Liver Disease Diagnostics Market Size by Type (2018-2023) & (US$ Million)
  • Table 22. Global Liver Disease Diagnostics Revenue Market Share by Type (2018-2023)
  • Table 23. Global Liver Disease Diagnostics Forecasted Market Size by Type (2024-2029) & (US$ Million)
  • Table 24. Global Liver Disease Diagnostics Revenue Market Share by Type (2024-2029)
  • Table 25. Global Liver Disease Diagnostics Market Size by Application (2018-2023) & (US$ Million)
  • Table 26. Global Liver Disease Diagnostics Revenue Market Share by Application (2018-2023)
  • Table 27. Global Liver Disease Diagnostics Forecasted Market Size by Application (2024-2029) & (US$ Million)
  • Table 28. Global Liver Disease Diagnostics Revenue Market Share by Application (2024-2029)
  • Table 29. North America Liver Disease Diagnostics Market Size by Type (2018-2023) & (US$ Million)
  • Table 30. North America Liver Disease Diagnostics Market Size by Type (2024-2029) & (US$ Million)
  • Table 31. North America Liver Disease Diagnostics Market Size by Application (2018-2023) & (US$ Million)
  • Table 32. North America Liver Disease Diagnostics Market Size by Application (2024-2029) & (US$ Million)
  • Table 33. North America Liver Disease Diagnostics Market Size by Country (2018-2023) & (US$ Million)
  • Table 34. North America Liver Disease Diagnostics Market Size by Country (2024-2029) & (US$ Million)
  • Table 35. Europe Liver Disease Diagnostics Market Size by Type (2018-2023) & (US$ Million)
  • Table 36. Europe Liver Disease Diagnostics Market Size by Type (2024-2029) & (US$ Million)
  • Table 37. Europe Liver Disease Diagnostics Market Size by Application (2018-2023) & (US$ Million)
  • Table 38. Europe Liver Disease Diagnostics Market Size by Application (2024-2029) & (US$ Million)
  • Table 39. Europe Liver Disease Diagnostics Market Size by Country (2018-2023) & (US$ Million)
  • Table 40. Europe Liver Disease Diagnostics Market Size by Country (2024-2029) & (US$ Million)
  • Table 41. Asia Pacific Liver Disease Diagnostics Market Size by Type (2018-2023) & (US$ Million)
  • Table 42. Asia Pacific Liver Disease Diagnostics Market Size by Type (2024-2029) & (US$ Million)
  • Table 43. Asia Pacific Liver Disease Diagnostics Market Size by Application (2018-2023) & (US$ Million)
  • Table 44. Asia Pacific Liver Disease Diagnostics Market Size by Application (2024-2029) & (US$ Million)
  • Table 45. Asia Pacific Liver Disease Diagnostics Market Size by Region (2018-2023) & (US$ Million)
  • Table 46. Asia Pacific Liver Disease Diagnostics Market Size by Region (2024-2029) & (US$ Million)
  • Table 47. Latin America Liver Disease Diagnostics Market Size by Type (2018-2023) & (US$ Million)
  • Table 48. Latin America Liver Disease Diagnostics Market Size by Type (2024-2029) & (US$ Million)
  • Table 49. Latin America Liver Disease Diagnostics Market Size by Application (2018-2023) & (US$ Million)
  • Table 50. Latin America Liver Disease Diagnostics Market Size by Application (2024-2029) & (US$ Million)
  • Table 51. Latin America Liver Disease Diagnostics Market Size by Country (2018-2023) & (US$ Million)
  • Table 52. Latin America Liver Disease Diagnostics Market Size by Country (2024-2029) & (US$ Million)
  • Table 53. Middle East & Africa Liver Disease Diagnostics Market Size by Type (2018-2023) & (US$ Million)
  • Table 54. Middle East & Africa Liver Disease Diagnostics Market Size by Type (2024-2029) & (US$ Million)
  • Table 55. Middle East & Africa Liver Disease Diagnostics Market Size by Application (2018-2023) & (US$ Million)
  • Table 56. Middle East & Africa Liver Disease Diagnostics Market Size by Application (2024-2029) & (US$ Million)
  • Table 57. Middle East & Africa Liver Disease Diagnostics Market Size by Country (2018-2023) & (US$ Million)
  • Table 58. Middle East & Africa Liver Disease Diagnostics Market Size by Country (2024-2029) & (US$ Million)
  • Table 59. Abbott Company Details
  • Table 60. Abbott Liver Disease Diagnostics Core Laboratory Menu
  • Table 61. Abbott Liver Disease Diagnostics Product
  • Table 62. Abbott Revenue in Liver Disease Diagnostics Business (2018-2023) & (US$ Million)
  • Table 63. Abbott Recent Development
  • Table 64. Roche Company Details
  • Table 65. Roche Liver Disease Diagnostics Product
  • Table 66. Roche Revenue in Liver Disease Diagnostics Business (2018-2023) & (US$ Million)
  • Table 67. Roche Recent Development
  • Table 68. Thermo Fisher Scientific Company Details
  • Table 69. Thermo Fisher Scientific Liver Disease Diagnostics Product
  • Table 70. Thermo Fisher Scientific Revenue in Liver Disease Diagnostics Business (2018-2023) & (US$ Million)
  • Table 71. Randox Diagnostic Centers Company Details
  • Table 72. Randox Diagnostic Centers Liver Disease Diagnostics Product
  • Table 73. Randox Diagnostic Centers Revenue in Liver Disease Diagnostics Business (2018-2023) & (US$ Million)
  • Table 74. Randox Diagnostic Centers Recent Development
  • Table 75. Boston Scientific Corporation Company Details
  • Table 76. Boston Scientific Corporation Liver Disease Diagnostics Product
  • Table 77. Boston Scientific Corporation Revenue in Liver Disease Diagnostics Business (2018-2023) & (US$ Million)
  • Table 78. LabCorp Company Details
  • Table 79. LabCorp Liver Disease Diagnostics Product
  • Table 80. LabCorp Revenue in Liver Disease Diagnostics Business (2018-2023) & (US$ Million)
  • Table 81. LabCorp Recent Development
  • Table 82. Fujifilm Corporation Company Details
  • Table 83. Fujifilm Corporation Liver Disease Diagnostics Product
  • Table 84. Fujifilm Corporation Revenue in Liver Disease Diagnostics Business (2018-2023) & (US$ Million)
  • Table 85. Siemens Healthineers Company Details
  • Table 86. Siemens Healthineers Liver Disease Diagnostics Product
  • Table 87. Siemens Healthineers Revenue in Liver Disease Diagnostics Business (2018-2023) & (US$ Million)
  • Table 88. BD Company Details
  • Table 89. BD Liver Disease Diagnostics Product
  • Table 90. BD Revenue in Liver Disease Diagnostics Business (2018-2023) & (US$ Million)
  • Table 91. Cook Medical Company Details
  • Table 92. Cook Medical Liver Disease Diagnostics Product
  • Table 93. Cook Medical Revenue in Liver Disease Diagnostics Business (2018-2023) & (US$ Million)
  • Table 94. GE Healthcare Company Details
  • Table 95. GE Healthcare Liver Disease Diagnostics Product
  • Table 96. GE Healthcare Revenue in Liver Disease Diagnostics Business (2018-2023) & (US$ Million)
  • Table 97. Philips Healthcare Company Details
  • Table 98. Philips Healthcare Liver Disease Diagnostics Product
  • Table 99. Philips Healthcare Revenue in Liver Disease Diagnostics Business (2018-2023) & (US$ Million)
  • Table 100. Philips Healthcare Recent Development
  • Table 101. Canon Medical Systems Company Details
  • Table 102. Canon Medical Systems Liver Disease Diagnostics Product
  • Table 103. Canon Medical Systems Revenue in Liver Disease Diagnostics Business (2018-2023) & (US$ Million)
  • Table 104. Canon Medical Systems Recent Development
  • Table 105. Qiagen Company Details
  • Table 106. Qiagen Liver Disease Diagnostics Product
  • Table 107. Qiagen Revenue in Liver Disease Diagnostics Business (2018-2023) & (US$ Million)
  • Table 108. Research Programs/Design for This Report
  • Table 109. Key Data Information from Secondary Sources
  • Table 110. Key Data Information from Primary Sources
  • Table 111. QYR Business Unit and Senior & Team Lead Analysts

List of Figures

  • Figure 1. Liver Disease Diagnostics
  • Figure 2. Global Liver Disease Diagnostics Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
  • Figure 3. Global Liver Disease Diagnostics Market Share by Type: 2022 VS 2029
  • Figure 4. Imaging Tests Features
  • Figure 5. Blood Tests Features
  • Figure 6. Biopsy Features
  • Figure 7. Global Liver Disease Diagnostics Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
  • Figure 8. Global Liver Disease Diagnostics Market Share by Application: 2022 VS 2029
  • Figure 9. Hospitals and Clinics Case Studies
  • Figure 10. Diagnostic Centers Case Studies
  • Figure 11. Others Case Studies
  • Figure 12. Liver Disease Diagnostics Report Years Considered
  • Figure 13. Global Liver Disease Diagnostics Market Size (US$ Million), Year-over-Year: 2018-2029
  • Figure 14. Global Liver Disease Diagnostics Market Size, (US$ Million), 2018 VS 2022 VS 2029
  • Figure 15. Global Liver Disease Diagnostics Market Share by Region: 2022 VS 2029
  • Figure 16. Global Liver Disease Diagnostics Market Share by Players in 2022
  • Figure 17. Global Top Liver Disease Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liver Disease Diagnostics as of 2022)
  • Figure 18. The Top 10 and 5 Players Market Share by Liver Disease Diagnostics Revenue in 2022
  • Figure 19. North America Liver Disease Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 20. North America Liver Disease Diagnostics Market Share by Type (2018-2029)
  • Figure 21. North America Liver Disease Diagnostics Market Share by Application (2018-2029)
  • Figure 22. North America Liver Disease Diagnostics Market Share by Country 2022
  • Figure 23. United States Liver Disease Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 24. Canada Liver Disease Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 25. Mexico Liver Disease Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 26. Europe Liver Disease Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 27. Europe Liver Disease Diagnostics Market Share by Type (2018-2029)
  • Figure 28. Europe Liver Disease Diagnostics Market Share by Application (2018-2029)
  • Figure 29. Europe Liver Disease Diagnostics Market Share by Country 2022
  • Figure 30. Germany Liver Disease Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 31. France Liver Disease Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 32. U.K. Liver Disease Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 33. Italy Liver Disease Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 34. Switzerland Liver Disease Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 35. Asia Pacific Liver Disease Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 36. Asia Pacific Liver Disease Diagnostics Market Share by Type (2018-2029)
  • Figure 37. Asia Pacific Liver Disease Diagnostics Market Share by Application (2018-2029)
  • Figure 38. Asia Pacific Liver Disease Diagnostics Market Share by Region 2022
  • Figure 39. China Liver Disease Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 40. Japan Liver Disease Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 41. South Korea Liver Disease Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 42. Southeast Asia Liver Disease Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 43. India Liver Disease Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 44. Australia Liver Disease Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 45. Latin America Liver Disease Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 46. Latin America Liver Disease Diagnostics Market Share by Type (2018-2029)
  • Figure 47. Latin America Liver Disease Diagnostics Market Share by Application (2018-2029)
  • Figure 48. Latin America Liver Disease Diagnostics Market Share by Country 2022
  • Figure 49. Brazil Liver Disease Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 50. Argentina Liver Disease Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 51. Middle East & Africa Liver Disease Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 52. Middle East & Africa Liver Disease Diagnostics Market Share by Type (2018-2029)
  • Figure 53. Middle East & Africa Liver Disease Diagnostics Market Share by Application (2018-2029)
  • Figure 54. Middle East & Africa Liver Disease Diagnostics Market Share by Country 2022
  • Figure 55. Saudi Arabia Liver Disease Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 56. UAE Liver Disease Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 57. Israel Liver Disease Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 58. Abbott Revenue Growth Rate in Liver Disease Diagnostics Business (2018-2023)
  • Figure 59. Roche Revenue Growth Rate in Liver Disease Diagnostics Business (2018-2023)
  • Figure 60. Thermo Fisher Scientific Revenue Growth Rate in Liver Disease Diagnostics Business (2018-2023)
  • Figure 61. Randox Diagnostic Centers Revenue Growth Rate in Liver Disease Diagnostics Business (2018-2023)
  • Figure 62. Boston Scientific Corporation Revenue Growth Rate in Liver Disease Diagnostics Business (2018-2023)
  • Figure 63. LabCorp Revenue Growth Rate in Liver Disease Diagnostics Business (2018-2023)
  • Figure 64. Fujifilm Corporation Revenue Growth Rate in Liver Disease Diagnostics Business (2018-2023)
  • Figure 65. Siemens Healthineers Revenue Growth Rate in Liver Disease Diagnostics Business (2018-2023)
  • Figure 66. BD Revenue Growth Rate in Liver Disease Diagnostics Business (2018-2023)
  • Figure 67. Cook Medical Revenue Growth Rate in Liver Disease Diagnostics Business (2018-2023)
  • Figure 68. GE Healthcare Revenue Growth Rate in Liver Disease Diagnostics Business (2018-2023)
  • Figure 69. Philips Healthcare Revenue Growth Rate in Liver Disease Diagnostics Business (2018-2023)
  • Figure 70. Canon Medical Systems Revenue Growth Rate in Liver Disease Diagnostics Business (2018-2023)
  • Figure 71. Qiagen Revenue Growth Rate in Liver Disease Diagnostics Business (2018-2023)
  • Figure 72. Bottom-up and Top-down Approaches for This Report
  • Figure 73. Data Triangulation
  • Figure 74. Key Executives Interviewed
目次

The global Liver Disease Diagnostics market is projected to grow from US$ 13,361.64 million in 2023 to US$ 20,102.98 million by 2029, at a Compound Annual Growth Rate (CAGR) of 7.05% during the forecast period.

North America Liver Disease Diagnostics market size is valued at US$ 5,019.20 million in 2022, while Asia Pacific and Europe Liver Disease Diagnostics are US$ 3,036.97 million and US$ 3,690.05 million, severally. The proportion of the North America is 40.95% in 2022, while APAC and Europe are 24.78% and 30.11% respectively, and it is predicted that APAC proportion will reach 28.57% in 2029, trailing a CAGR of 8.99% through the analysis period. China, Japan, South Korea, and India are noteworthy markets in APAC. As for the Europe Liver Disease Diagnostics landscape, Germany is projected to reach US$ 1,292.90 million by 2029 trailing a CAGR of 6.06% during 2023-2029.

The global key companies of Liver Disease Diagnostics include: Roche, Abbott, Thermo Fisher Scientific, Siemens Healthineers, GE Healthcare, Canon Medical Systems, LabCorp, BD, Philips Healthcare and Randox Laboratories is the leading manufacturer in global Liver Disease Diagnostics market. The top 10 listed companies accounted for 39.41% of the market share in 2022 in terms of revenue.

Report Includes:

This report presents an overview of global market for Liver Disease Diagnostics market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.

This report researches the key producers of Liver Disease Diagnostics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Liver Disease Diagnostics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Liver Disease Diagnostics revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Liver Disease Diagnostics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Liver Disease Diagnostics revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Abbott, Roche, Thermo Fisher Scientific, Randox Diagnostic Centers, Boston Scientific Corporation, LabCorp, Fujifilm Corporation, Horiba Medical, and Siemens Healthineers, etc.

By Company

  • Abbott
  • Roche
  • Thermo Fisher Scientific
  • Randox Laboratories
  • Boston Scientific
  • LabCorp
  • Fujifilm Corporation
  • Siemens Healthineers
  • BD
  • Cook Medical
  • GE Healthcare
  • Philips Healthcare
  • Canon Medical Systems
  • Qiagen

Segment by Type

  • Imaging Tests
  • Blood Tests
  • Biopsy

Segment by Application

  • Hospitals and Clinics
  • Diagnostic Centers
  • Others

By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Switzerland
    • Rest of Europe
  • Latin America
    • Brazil
    • Argentina
    • Rest of Latin America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Israel
    • Rest of MEA

Table of Contents

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Liver Disease Diagnostics Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
    • 1.2.2 Imaging Tests
    • 1.2.3 Blood Tests
    • 1.2.4 Biopsy
  • 1.3 Market by Application
    • 1.3.1 Global Liver Disease Diagnostics Market Share by Application: 2018 VS 2022 VS 2029
    • 1.3.2 Hospitals and Clinics
    • 1.3.3 Diagnostic Centers
    • 1.3.4 Others
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Global Growth Trends

  • 2.1 Global Liver Disease Diagnostics Market Perspective (2018-2029)
  • 2.2 Global Liver Disease Diagnostics Growth Trends by Region
    • 2.2.1 Global Liver Disease Diagnostics Market Size by Region: 2018 VS 2022 VS 2029
    • 2.2.2 Liver Disease Diagnostics Historic Market Size by Region (2018-2023)
    • 2.2.3 Liver Disease Diagnostics Forecasted Market Size by Region (2024-2029)
  • 2.3 Liver Disease Diagnostics Market Dynamics
    • 2.3.1 Liver Disease Diagnostics Industry Trends
    • 2.3.2 Liver Disease Diagnostics Market Drivers
    • 2.3.3 Liver Disease Diagnostics Market Challenges
    • 2.3.4 Liver Disease Diagnostics Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Revenue Liver Disease Diagnostics by Players
    • 3.1.1 Global Liver Disease Diagnostics Revenue by Players (2018-2023)
    • 3.1.2 Global Liver Disease Diagnostics Revenue Market Share by Players (2018-2023)
  • 3.2 Global Liver Disease Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Global Key Players of Liver Disease Diagnostics, Ranking by Revenue
  • 3.4 Global Liver Disease Diagnostics Market Concentration Ratio
    • 3.4.1 Global Liver Disease Diagnostics Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Liver Disease Diagnostics Revenue in 2022
  • 3.5 Global Key Players of Liver Disease Diagnostics Head office and Manufacturing Sites
  • 3.6 Global Key Players of Liver Disease Diagnostics Product
  • 3.7 Global Key Players of Liver Disease Diagnostics, Founded Date
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Liver Disease Diagnostics Breakdown Data by Type

  • 4.1 Global Liver Disease Diagnostics Historic Market Size by Type (2018-2023)
  • 4.2 Global Liver Disease Diagnostics Forecasted Market Size by Type (2024-2029)

5 Liver Disease Diagnostics Breakdown Data by Application

  • 5.1 Global Liver Disease Diagnostics Historic Market Size by Application (2018-2023)
  • 5.2 Global Liver Disease Diagnostics Forecasted Market Size by Application (2024-2029)

6 North America

  • 6.1 North America Liver Disease Diagnostics Market Size (2018-2029)
  • 6.2 North America Liver Disease Diagnostics Market Size by Type
    • 6.2.1 North America Liver Disease Diagnostics Market Size by Type (2018-2023)
    • 6.2.2 North America Liver Disease Diagnostics Market Size by Type (2024-2029)
    • 6.2.3 North America Liver Disease Diagnostics Market Share by Type (2018-2029)
  • 6.3 North America Liver Disease Diagnostics Market Size by Application
    • 6.3.1 North America Liver Disease Diagnostics Market Size by Application (2018-2023)
    • 6.3.2 North America Liver Disease Diagnostics Market Size by Application (2024-2029)
    • 6.3.3 North America Liver Disease Diagnostics Market Share by Application (2018-2029)
  • 6.4 North America Liver Disease Diagnostics Market Size by Country
    • 6.4.1 North America Liver Disease Diagnostics Market Size by Country (2018-2023)
    • 6.4.2 North America Liver Disease Diagnostics Market Share by Country (2024-2029)
    • 6.4.3 United States
    • 6.4.4 Canada
    • 6.4.5 Mexico

7 Europe

  • 7.1 Europe Liver Disease Diagnostics Market Size (2018-2029)
  • 7.2 Europe Liver Disease Diagnostics Market Size by Type
    • 7.2.1 Europe Liver Disease Diagnostics Market Size by Type (2018-2023)
    • 7.2.2 Europe Liver Disease Diagnostics Market Size by Type (2024-2029)
    • 7.2.3 Europe Liver Disease Diagnostics Market Share by Type (2018-2029)
  • 7.3 Europe Liver Disease Diagnostics Market Size by Application
    • 7.3.1 Europe Liver Disease Diagnostics Market Size by Application (2018-2023)
    • 7.3.2 Europe Liver Disease Diagnostics Market Size by Application (2024-2029)
    • 7.3.3 Europe Liver Disease Diagnostics Market Share by Application (2018-2029)
  • 7.4 Europe Liver Disease Diagnostics Market Size by Country
    • 7.4.1 Europe Liver Disease Diagnostics Market Size by Country (2018-2023)
    • 7.4.2 Europe Liver Disease Diagnostics Market Size by Country (2024-2029)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Switzerland

8 Asia Pacific

  • 8.1 Asia Pacific Liver Disease Diagnostics Market Size (2018-2029)
  • 8.2 Asia Pacific Liver Disease Diagnostics Market Size by Type
    • 8.2.1 Asia Pacific Liver Disease Diagnostics Market Size by Type (2018-2023)
    • 8.2.2 Asia Pacific Liver Disease Diagnostics Market Size by Type (2024-2029)
    • 8.2.3 Asia Pacific Liver Disease Diagnostics Market Share by Type (2018-2029)
  • 8.3 Asia Pacific Liver Disease Diagnostics Market Size by Application
    • 8.3.1 Asia Pacific Liver Disease Diagnostics Market Size by Application (2018-2023)
    • 8.3.2 Asia Pacific Liver Disease Diagnostics Market Size by Application (2024-2029)
    • 8.3.3 Asia Pacific Liver Disease Diagnostics Market Share by Application (2018-2029)
  • 8.4 Asia Pacific Liver Disease Diagnostics Market Size by Region
    • 8.4.1 Asia Pacific Liver Disease Diagnostics Market Size by Region (2018-2023)
    • 8.4.2 Asia Pacific Liver Disease Diagnostics Market Size by Region (2024-2029)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Liver Disease Diagnostics Market Size (2018-2029)
  • 9.2 Latin America Liver Disease Diagnostics Market Size by Type
    • 9.2.1 Latin America Liver Disease Diagnostics Market Size by Type (2018-2023)
    • 9.2.2 Latin America Liver Disease Diagnostics Market Size by Type (2024-2029)
    • 9.2.3 Latin America Liver Disease Diagnostics Market Share by Type (2018-2029)
  • 9.3 Latin America Liver Disease Diagnostics Market Size by Application
    • 9.3.1 Latin America Liver Disease Diagnostics Market Size by Application (2018-2023)
    • 9.3.2 Latin America Liver Disease Diagnostics Market Size by Application (2024-2029)
    • 9.3.3 Latin America Liver Disease Diagnostics Market Share by Application (2018-2029)
  • 9.4 Latin America Liver Disease Diagnostics Market Size by Country
    • 9.4.1 Latin America Liver Disease Diagnostics Market Size by Country (2018-2023)
    • 9.4.2 Latin America Liver Disease Diagnostics Market Size by Country (2024-2029)
    • 9.4.3 Brazil
    • 9.4.4 Argentina

10 Middle East & Africa

  • 10.1 Middle East & Africa Liver Disease Diagnostics Market Size (2018-2029)
  • 10.2 Middle East & Africa Liver Disease Diagnostics Market Size by Type
    • 10.2.1 Middle East & Africa Liver Disease Diagnostics Market Size by Type (2018-2023)
    • 10.2.2 Middle East & Africa Liver Disease Diagnostics Market Size by Type (2024-2029)
    • 10.2.3 Middle East & Africa Liver Disease Diagnostics Market Share by Type (2018-2029)
  • 10.3 Middle East & Africa Liver Disease Diagnostics Market Size by Application
    • 10.3.1 Middle East & Africa Liver Disease Diagnostics Market Size by Application (2018-2023)
    • 10.3.2 Middle East & Africa Liver Disease Diagnostics Market Size by Application (2024-2029)
    • 10.3.3 Middle East & Africa Liver Disease Diagnostics Market Share by Application (2018-2029)
  • 10.4 Middle East & Africa Liver Disease Diagnostics Market Size by Country
    • 10.4.1 Middle East & Africa Liver Disease Diagnostics Market Size by Country (2018-2023)
    • 10.4.2 Middle East & Africa Liver Disease Diagnostics Market Size by Country (2024-2029)
    • 10.4.3 Saudi Arabia
    • 10.4.4 UAE
    • 10.4.5 Israel

11 Key Players Profiles

  • 11.1 Abbott
    • 11.1.1 Abbott Company Details
    • 11.1.2 Abbott Business Overview
    • 11.1.3 Abbott Liver Disease Diagnostics Introduction
    • 11.1.4 Abbott Revenue in Liver Disease Diagnostics Business (2018-2023)
    • 11.1.5 Abbott Recent Development
  • 11.2 Roche
    • 11.2.1 Roche Company Details
    • 11.2.2 Roche Business Overview
    • 11.2.3 Roche Liver Disease Diagnostics Introduction
    • 11.2.4 Roche Revenue in Liver Disease Diagnostics Business (2018-2023)
    • 11.2.5 Roche Recent Development
  • 11.3 Thermo Fisher Scientific
    • 11.3.1 Thermo Fisher Scientific Company Details
    • 11.3.2 Thermo Fisher Scientific Business Overview
    • 11.3.3 Thermo Fisher Scientific Liver Disease Diagnostics Introduction
    • 11.3.4 Thermo Fisher Scientific Revenue in Liver Disease Diagnostics Business (2018-2023)
  • 11.4 Randox Diagnostic Centers
    • 11.4.1 Randox Diagnostic Centers Company Details
    • 11.4.2 Randox Diagnostic Centers Business Overview
    • 11.4.3 Randox Diagnostic Centers Liver Disease Diagnostics Introduction
    • 11.4.4 Randox Diagnostic Centers Revenue in Liver Disease Diagnostics Business (2018-2023)
    • 11.4.5 Randox Diagnostic Centers Recent Development
  • 11.5 Boston Scientific Corporation
    • 11.5.1 Boston Scientific Corporation Company Details
    • 11.5.2 Boston Scientific Corporation Business Overview
    • 11.5.3 Boston Scientific Corporation Liver Disease Diagnostics Introduction
    • 11.5.4 Boston Scientific Corporation Revenue in Liver Disease Diagnostics Business (2018-2023)
  • 11.6 LabCorp
    • 11.6.1 LabCorp Company Details
    • 11.6.2 LabCorp Business Overview
    • 11.6.3 LabCorp Liver Disease Diagnostics Introduction
    • 11.6.4 LabCorp Revenue in Liver Disease Diagnostics Business (2018-2023)
    • 11.6.5 LabCorp Recent Development
  • 11.7 Fujifilm Corporation
    • 11.7.1 Fujifilm Corporation Company Details
    • 11.7.2 Fujifilm Corporation Business Overview
    • 11.7.3 Fujifilm Corporation Liver Disease Diagnostics Introduction
    • 11.7.4 Fujifilm Corporation Revenue in Liver Disease Diagnostics Business (2018-2023)
  • 11.8 Siemens Healthineers
    • 11.8.1 Siemens Healthineers Company Details
    • 11.8.2 Siemens Healthineers Business Overview
    • 11.8.3 Siemens Healthineers Liver Disease Diagnostics Introduction
    • 11.8.4 Siemens Healthineers Revenue in Liver Disease Diagnostics Business (2018-2023)
  • 11.9 BD
    • 11.9.1 BD Company Details
    • 11.9.2 BD Business Overview
    • 11.9.3 BD Liver Disease Diagnostics Introduction
    • 11.9.4 BD Revenue in Liver Disease Diagnostics Business (2018-2023)
  • 11.10 Cook Medical
    • 11.10.1 Cook Medical Company Details
    • 11.10.2 Cook Medical Business Overview
    • 11.10.3 Cook Medical Liver Disease Diagnostics Introduction
    • 11.10.4 Cook Medical Revenue in Liver Disease Diagnostics Business (2018-2023)
  • 11.11 GE Healthcare
    • 11.11.1 GE Healthcare Company Details
    • 11.11.2 GE Healthcare Business Overview
    • 11.11.3 GE Healthcare Liver Disease Diagnostics Introduction
    • 11.11.4 GE Healthcare Revenue in Liver Disease Diagnostics Business (2018-2023)
  • 11.12 Philips Healthcare
    • 11.12.1 Philips Healthcare Company Details
    • 11.12.2 Philips Healthcare Business Overview
    • 11.12.3 Philips Healthcare Liver Disease Diagnostics Introduction
    • 11.12.4 Philips Healthcare Revenue in Liver Disease Diagnostics Business (2018-2023)
    • 11.12.5 Philips Healthcare Recent Development
  • 11.13 Canon Medical Systems
    • 11.13.1 Canon Medical Systems Company Details
    • 11.13.2 Canon Medical Systems Business Overview
    • 11.13.3 Canon Medical Systems Liver Disease Diagnostics Introduction
    • 11.13.4 Canon Medical Systems Revenue in Liver Disease Diagnostics Business (2018-2023)
    • 11.13.5 Canon Medical Systems Recent Development
  • 11.14 Qiagen
    • 11.14.1 Qiagen Company Details
    • 11.14.2 Qiagen Business Overview
    • 11.14.3 Qiagen Liver Disease Diagnostics Introduction
    • 11.14.4 Qiagen Revenue in Liver Disease Diagnostics Business (2018-2023)

12 Analyst's Viewpoints/Conclusions

13 Appendix

  • 13.1 Research Methodology
    • 13.1.1 Methodology/Research Approach
    • 13.1.2 Data Source
  • 13.2 Author Details
  • 13.3 Disclaimer